IB Acquisition Corp. (IBACR) stock
IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC
$0.10−0.00 (-3.50%)
Close on Oct 30, 2026Market cap $54.39MP/E –Yield –
IB Acquisition cash
Cash and short-term investments held at the end of each period.
IB Acquisition's cash was $30.16K at Jun 30, 2026. For fiscal 2025 it was $428.70K, down 47.9% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $428.70K | -47.9% |
| FY2024 | Sep 30, 2024 | $822.80K | +1465.7% |
| FY2023 | Sep 30, 2023 | $52.55K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Jun 30, 2026 | $30.16K | -93.8% |
| Q2 FY2026 | Mar 31, 2026 | $4.63K | -99.3% |
| Q1 FY2026 | Dec 31, 2025 | $165.48K | -81.8% |
| Q4 FY2025 | Sep 30, 2025 | $428.70K | -47.9% |
| Q3 FY2025 | Jun 30, 2025 | $486.02K | -44.6% |
| Q2 FY2025 | Mar 31, 2025 | $627.38K | -62.2% |
| Q1 FY2025 | Dec 31, 2024 | $910.19K | +1632.0% |
| Q4 FY2024 | Sep 30, 2024 | $822.80K | – |
| Q3 FY2024 | Jun 30, 2024 | $876.65K | – |
| Q2 FY2024 | Mar 31, 2024 | $1.66M | – |
| Q4 FY2023 | Sep 30, 2023 | $52.55K | – |